Form 8-K - Current report:
SEC Accession No. 0001628280-21-001524
Filing Date
2021-02-05
Accepted
2021-02-05 16:25:30
Documents
17
Period of Report
2021-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20210201.htm   iXBRL 8-K 45148
2 EX-1.1 exhibit11-8xk2521.htm EX-1.1 230873
3 EX-5.1 exhibit51-8xk2521.htm EX-5.1 20032
9 exhibit512.jpg GRAPHIC 20696
  Complete submission text file 0001628280-21-001524.txt   533059

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20210201.xsd EX-101.SCH 2421
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20210201_cal.xml EX-101.CAL 712
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20210201_def.xml EX-101.DEF 1649
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20210201_lab.xml EX-101.LAB 25998
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20210201_pre.xml EX-101.PRE 13733
10 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20210201_htm.xml XML 11655
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 21595801
SIC: 2834 Pharmaceutical Preparations